Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

eCase: Accurate Diagnosis Leads to Appropriate Treatment Selection in Patients With Bipolar Depression
  • CME
  • CE

This eCase explores accurately diagnosing and individualizing treatment in a patient with bipolar depression.
Leslie Citrome, MD, MPH
Program Director
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Physician Assistants: maximum of 1.0 hour of AAPA Category 1 CME credits
Psychologists: 1.0 APA CE Credit
Social Workers: 1.0 ACE CE Credit
Released: September 30, 2022 Expiration: September 29, 2023

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Discuss the differential diagnosis of bipolar depression and major depressive disorder and identify patients at risk
  • Differentiate the available treatment options for patients with bipolar depression based on patient-specific characteristics
  • Construct evidence-based patient treatment plans based on patient and disease state-specific characteristics

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie Inc.
Intra-Cellular Therapies, Inc.

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Program Director

Leslie Citrome, MD, MPH

Clinical Professor
Department of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York

Leslie Citrome, MD, MPH: consultant: AbbVie/Allergan, Acadia, Adamas, Alkermes, Angelini, Astellas, Avanir, Axsome, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Cerevel, Clinilabs, COMPASS, Eisai, Enteris BioPharma, HLS Therapeutics, Idorsia, INmune Bio, Impel, Intra-Cellular Therapies, Janssen, Karuna, Lundbeck, Lyndra, Medavante-ProPhase, Marvin, Merck, Mitsubishi-Tanabe Pharma, Neurocrine, Neurelis, Novartis, Noven, Otsuka, Ovid, Praxis, Recordati, Relmada, Reviva, Sage, Sunovion, Supernus, Teva, University of Arizona; speaker: AbbVie/Allergan, Acadia, Alkermes, Angelini, Axsome, BioXcel, Eisai, Idorsia, Intra-Cellular Therapies, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Recordati, Sage, Sunovion, Takeda, Teva, Medscape, NACCME, NEI, Vindico; stocks/stock options: Bristol-Myers Squibb, Johnson & Johnson, Lilly, Merck, Pfizer, Reviva.

Staff

Stephanie Filice, LICSW
Stephanie Filice, LICSW, has no relevant financial relationships to disclose.
Raquel Gaerlan

Director, Scientific Services

Raquel Gaerlan has no relevant financial relationships to disclose.
Gabrielle Giacona

Associate Scientific Director

Gabrielle Giacona: individual publicly traded stocks/stock options: AstraZeneca, Moderna, Teva.
Amber Lemons, PharmD, BCPP

Director, Educational Strategy

Amber Lemons, PharmD, BCPP, has no relevant financial relationships to disclose.
Lisa Phipps, PharmD, PhD

Director, Science and Strategy, Neuroscience

Lisa Phipps, PharmD, PhD, has no relevant financial relationships to disclose.
Dace Svikis, PhD

Professor
Department of Psychology
Virginia Commonwealth University
Richmond, Virginia

Dace S. Svikis, PhD, has no relevant financial relationships to disclose.
Amanda Zimmerman, PA-C

Physician Assistant
West Forsyth Pain Management
Winston-Salem, North Carolina

Amanda Zimmerman, PA-C, researcher: Biodelivery Sciences International.
Julie Skowronski, NP
Julie Skowronski, NP, has no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This activity is intended for psychiatrists, nurse practitioners, physician associates/physician assistants, nurses, pharmacists, psychologists, and social workers engaged in the care of patients with psychiatric illness.

Goal

The goal of this activity is to use a patient case study to improve the knowledge, competence, and performance of healthcare professionals in evaluating diagnostic considerations and treatment options for bipolar depression.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-233-H01-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until September 29, 2023. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity offers 1.0 continuing education credit for psychologists.

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC (CCO) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. CCO maintains responsibility for this course. Social workers completing this course receive 1.0 clinical continuing education credit.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from September 30, 2022, through September 29, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Downloadable slides from the major depressive disorder presentation at the 2022 Psychopharmacology Update conference (CCO)

Greg W. Mattingly, MD Released: December 1, 2022

Downloadable slides from the antidepressants presentation at the 8th Annual Psychopharmacology Update 2022 (CCO)

Anita Clayton, MD Released: December 1, 2022

Downloadable slides from the ADHD presentation at the 8th Annual Psychopharmacology Update 2022 (CCO)

Vladimir Maletic, MD Released: November 30, 2022

Downloadable slides from the LAI antipsychotics presentation at the 2022 Psychopharmacology Update conference, from Clinical Care Options (CCO)

Leslie Citrome, MD, MPH Released: November 30, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings